Arrowstreet Capital’s Atea Pharmaceuticals AVIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.13M Buy
2023
Q3
Sell
2023
Q2
$380K Buy
2022
Q3
Sell
2022
Q2
$77K Buy
2022
Q1
Sell
2021
Q4
$919K Sell
2021
Q3
$6.26M Buy
2021
Q2
$2.81M Buy